A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency

Clinical Cancer Research

Volumn 7, Issue 1, 2001, Pages 120-126

  Suzuki, Kaori ^a   Fueyo, Juan ^b   Krasnykh, Victor ^a   Reynolds, Paul N ^a   Curiel, David T ^a   Alemany, Ramon ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADENOVIRUS; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOLYSIS; CYTOTOXICITY; DNA MODIFICATION; DNA REPLICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; CELL DIVISION; FEMALE; FORMAZANS; GENETIC VECTORS; HUMANS; IMMUNOLOGIC TESTS; LUCIFERASES; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIRUS REPLICATION; VIRUSES;

EID: 0035138689     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Replicating viruses as selective cancer therapeutics
2. Replicating vectors for cancer therapy: A question of strategy
3. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
4. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
5. A Phase 1 study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
6. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
7. The presence of human Coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
8. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and δE1B adenovirus replication in human cells
9. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
10. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
11. 5may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells
12. Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression
13. 3integrin. Adhesion mechanism for transformed glial cells
14. νintegrins as receptors for tumor targeting by circulating ligands
15. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a Coxsackievirus and adenovirus receptor-independent cell entry mechanism
16. Selective gene delivery to head and neck cancer cells via an integrin-targeted adenoviral vector
17. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
18. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
19. A cell cycle regulator potentially involved in genesis of many tumor types
20. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer
21. 1regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells
22. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5
23. Construction of adenovirus vectors through Cre-lox recombination
24. 3integrin is modulated by a focal adhesion kinase pathway
25. Expression of cellular adhesion molecules on human prostate tumor cell lines
26. Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses
27. Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus
28. Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: Intratumoral spread and distribution effects
29. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas
30. Identification of receptor ligands with phage display peptide libraries
31. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae